Brodalumab vs Tofacitinib

Brodalumab vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Brodalumab and Tofacitinib.

Mechanism of Action

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Tofacitinib — C16H20N6O.

Molecular Weight: Tofacitinib — 312.3700 g/mol.

Type: Brodalumab — Antibody; Tofacitinib — Small molecule.